Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression

scientific article published on 01 January 2004

Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEULET.2003.09.062
P698PubMed publication ID14698484

P50authorMartin WiesmannQ56972564
Thomas F MünteQ86352775
Volker AroltQ110551284
P2093author name stringYuanyuan Zhang
Sönke Johannes
Marion Peters
Hinderk M Emrich
Matthias Rothermundt
Detlef E Dietrich
Holger Kirchner
Sebastian Rudolf
Mark Hasselmann
Oliver Jüngling
Ute Hauser
P433issue1
P304page(s)69-73
P577publication date2004-01-01
P1433published inNeuroscience LettersQ7002625
P1476titleTarget evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression
P478volume354

Reverse relations

cites work (P2860)
Q34374437Blood levels of S-100 calcium-binding protein B, high-sensitivity C-reactive protein, and interleukin-6 for changes in depressive symptom severity after coronary artery bypass grafting: prospective cohort nested within a randomized, controlled trial
Q35002122Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor
Q37344751Neuropsychiatric disorders related to interferon and interleukins treatment
Q35330647Serum S100B Protein Levels in Patients with Panic Disorder: Effect of Treatment with Selective Serotonine Reuptake Inhibitors.
Q61809206Serum S100B levels in patients with depression
Q45022287The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment
Q48848861The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression

Search more.